Launch Therapeutics
PrivateLast Round
Corporate Funding
Apr 11, 2022
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Launch Therapeutics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Corporate Funding round in April 2022.
Launch Therapeutics is a clinical development company that provides pharmaceutical and biotech partners with capital and expertise in drug development, clinical operations, and regulatory strategy to accelerate late-stage clinical programs.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Compliance & Risk
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Launch Therapeutics Comparables
Compare Launch Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avillion Life Sciences | 91% | |
| SFJ Pharmaceuticals | 88% | |
| Blackstone Loan Financing Limited | 78% |
For institutional investors. Book with your work email.
Launch Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Apr 11, 2022 |
For institutional investors. Book with your work email.
Launch Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Carlyle Group | Corporate Funding |
| Abingworth | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 150% MoM, reaching 2.8K.
- May 16, 2026
Monthly visitors grew 144% MoM, reaching 1.9K.
For institutional investors. Book with your work email.
Launch Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Launch Therapeutics's valuation, stock price, and market status.
Is Launch Therapeutics a public or private company?
Launch Therapeutics is a private company.
What is the current stock price of Launch Therapeutics?
Launch Therapeutics is a private company, so its shares have no public market price. Caplight tracks Launch Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Launch Therapeutics worth (valuation)?
Valuation information for Launch Therapeutics is not publicly available.
Can I buy Launch Therapeutics stock?
Launch Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Launch Therapeutics's last funding round?
Launch Therapeutics's most recent funding round was Corporate Funding on April 11, 2022.
Who are the main investors in Launch Therapeutics?
Key investors in Launch Therapeutics include The Carlyle Group, Abingworth.
Will Launch Therapeutics IPO soon?
No public IPO plans have been announced for Launch Therapeutics.
How can I track Launch Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Launch Therapeutics's shares on secondary markets.